ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 121 filers reported holding ADAMAS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $7,000 | -12.5% | 973 | 0.0% | 0.00% | – |
| Q4 2018 | $8,000 | -57.9% | 973 | 0.0% | 0.00% | – |
| Q3 2018 | $19,000 | -13.6% | 973 | +15.1% | 0.00% | – |
| Q2 2018 | $22,000 | +10.0% | 845 | 0.0% | 0.00% | – |
| Q1 2018 | $20,000 | -31.0% | 845 | 0.0% | 0.00% | – |
| Q4 2017 | $29,000 | +61.1% | 845 | 0.0% | 0.00% | – |
| Q3 2017 | $18,000 | -28.0% | 845 | -41.2% | 0.00% | – |
| Q2 2017 | $25,000 | 0.0% | 1,438 | +1.8% | 0.00% | – |
| Q1 2017 | $25,000 | +38.9% | 1,413 | +33.1% | 0.00% | – |
| Q4 2016 | $18,000 | +12.5% | 1,062 | +6.0% | 0.00% | – |
| Q3 2016 | $16,000 | +14.3% | 1,002 | +7.2% | 0.00% | – |
| Q2 2016 | $14,000 | +27.3% | 935 | +23.7% | 0.00% | – |
| Q1 2016 | $11,000 | -45.0% | 756 | +8.5% | 0.00% | – |
| Q4 2015 | $20,000 | +81.8% | 697 | +5.6% | 0.00% | – |
| Q3 2015 | $11,000 | -31.2% | 660 | +9.5% | 0.00% | – |
| Q2 2015 | $16,000 | – | 603 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,423,578 | $8,826,000 | 6.08% |
| Healthcare Value Capital, LLC | 200,000 | $1,240,000 | 2.33% |
| ARMISTICE CAPITAL, LLC | 2,700,000 | $16,740,000 | 1.06% |
| DELTEC ASSET MANAGEMENT LLC | 550,836 | $3,415,000 | 0.75% |
| Broadfin Capital, LLC | 441,088 | $2,735,000 | 0.60% |
| Kerrisdale Advisers, LLC | 229,347 | $1,422,000 | 0.51% |
| Worth Venture Partners, LLC | 87,908 | $545,000 | 0.30% |
| Mosaic Family Wealth, LLC | 91,314 | $566,000 | 0.24% |
| EMERALD ADVISERS, LLC | 700,176 | $4,341,000 | 0.17% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 616,664 | $3,823,000 | 0.15% |